LONG-TERM TREATMENT WITH INTRAVENOUS IMMU NOGLOBULIN IN PATIENTS WITHCHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, MYASTHENIA AND IN MULTIFOCAL MOTOR NEUROPATHY

This retrospective study was aimed at intermittent intravenous immunog lobulin therapy in severe cases of chronic Guillain Barre syndrome (8 cases), myasthenia (5) and in multifocal motor neuropathy (MMN) (2). O n an average, IVIG therapy was performed 9 times. There was a goad res ponse in CIDP, myasthenia and in MMN. After 6 months a decrease of IVI G response was seen in CIDP, but not in myasthenia and not in MMN. We conclude that intermittent IVIG treatment is an alternative in severe courses of these neuromuscular diseases.